Literature DB >> 16505359

Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells.

Bradley W Schuller1, Peter J Binns, Kent J Riley, Ling Ma, M Frederick Hawthorne, Jeffrey A Coderre.   

Abstract

The possible role of vascular endothelial cell damage in the loss of intestinal crypt stem cells and the subsequent development of the gastrointestinal (GI) syndrome is addressed. Mice received whole-body epithermal neutron irradiation at a dose rate of 0.57 +/- 0.04 Gy x min(-1). An additional dose was selectively targeted to endothelial cells from the short-ranged (5-9 microm) particles released from neutron capture reactions in 10B confined to the blood by incorporation into liposomes 70-90 nm in diameter. Different liposome formulations produced 45 +/- 7 or 118 +/- 12 microg/g 10B in the blood at the time of neutron irradiation, which resulted in total absorbed dose rates in the endothelial cells of 1.08 +/- 0.09 or 1.90 +/- 0.16 Gy x min(-1), respectively. At 3.5 d after irradiation, the intestinal crypt microcolony assay showed that the 2- to 3-fold increased doses to the microvasculature, relative to the nonspecific whole-body neutron beam doses, caused no additional crypt stem cell loss beyond that produced by the neutron beam alone. The threshold dose for death from the GI syndrome after neutron-beam-only irradiation was 9.0 +/- 0.6 Gy. There were no deaths from the GI syndrome, despite calculated absorbed doses to endothelial cells as high as 27.7 Gy, in the groups that received neutron beam doses of <9.0 Gy with boronated liposomes in the blood. These data indicate that endothelial cell damage is not causative in the loss of intestinal crypt stem cells and the eventual development of the GI syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505359      PMCID: PMC1383492          DOI: 10.1073/pnas.0600133103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine.

Authors:  Christopher S Potten
Journal:  Radiat Res       Date:  2004-02       Impact factor: 2.841

2.  Microvascular function regulates intestinal crypt response to radiation.

Authors:  Jerzy G Maj; François Paris; Adriana Haimovitz-Friedman; Ennapadam Venkatraman; Richard Kolesnick; Zvi Fuks
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

3.  Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation.

Authors:  H R Withers; M M Elkind
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1970

4.  ATM regulates target switching to escalating doses of radiation in the intestines.

Authors:  Hui-Ju Ch'ang; Jerzy G Maj; François Paris; H Rosie Xing; Jianjun Zhang; Jean-Philip Truman; Carlos Cardon-Cardo; Adriana Haimovitz-Friedman; Richard Kolesnick; Zvi Fuks
Journal:  Nat Med       Date:  2005-05-01       Impact factor: 53.440

5.  Performance characteristics of the MIT fission converter based epithermal neutron beam.

Authors:  K J Riley; P J Binns; O K Harling
Journal:  Phys Med Biol       Date:  2003-04-07       Impact factor: 3.609

6.  Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

Authors:  F Paris; Z Fuks; A Kang; P Capodieci; G Juan; D Ehleiter; A Haimovitz-Friedman; C Cordon-Cardo; R Kolesnick
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

7.  Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy.

Authors:  John Gueulette; Michèle Octave-Prignot; Blanche-Marie De Costera; André Wambersie; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2004-12       Impact factor: 6.280

Review 8.  Radiation and ceramide-induced apoptosis.

Authors:  Richard Kolesnick; Zvi Fuks
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

9.  Identification of a putative intestinal stem cell and early lineage marker; musashi-1.

Authors:  Christopher S Potten; Catherine Booth; Gregory L Tudor; Dawn Booth; Gerard Brady; Patricia Hurley; Gary Ashton; Robert Clarke; Shin-ichi Sakakibara; Hideyuki Okano
Journal:  Differentiation       Date:  2003-01       Impact factor: 3.880

Review 10.  The radiotherapeutic injury--a complex 'wound'.

Authors:  James W Denham; Martin Hauer-Jensen
Journal:  Radiother Oncol       Date:  2002-05       Impact factor: 6.280

View more
  21 in total

Review 1.  Radiation enteropathy--pathogenesis, treatment and prevention.

Authors:  Martin Hauer-Jensen; James W Denham; H Jervoise N Andreyev
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-01       Impact factor: 46.802

Review 2.  Proton RBE dependence on dose in the setting of hypofractionation.

Authors:  Thomas Friedrich
Journal:  Br J Radiol       Date:  2019-08-28       Impact factor: 3.039

Review 3.  Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy.

Authors:  Erqi L Pollom; Lei Deng; Reetesh K Pai; J Martin Brown; Amato Giaccia; Billy W Loo; David B Shultz; Quynh Thu Le; Albert C Koong; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-01       Impact factor: 7.038

4.  Apoptosis and expression of apoptosis-related genes in mouse intestinal tissue after whole-body proton exposure.

Authors:  Ashley Purgason; Ye Zhang; Stanley R Hamilton; Daila S Gridley; Ayodotun Sodipe; Olufisayo Jejelowo; Govindarajan T Ramesh; Maria Moreno-Villanueva; Honglu Wu
Journal:  Mol Cell Biochem       Date:  2017-11-02       Impact factor: 3.396

5.  Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice.

Authors:  Catherine Booth; Gregory Tudor; Nicola Tonge; Terez Shea-Donohue; Thomas J MacVittie
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

Review 6.  Mechanisms of radiation-induced brain toxicity and implications for future clinical trials.

Authors:  Jae Ho Kim; Stephen L Brown; Kenneth A Jenrow; Samuel Ryu
Journal:  J Neurooncol       Date:  2008-01-22       Impact factor: 4.130

Review 7.  Gastrointestinal radiation injury: symptoms, risk factors and mechanisms.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

8.  Normal tissue protection for improving radiotherapy: Where are the Gaps?

Authors:  Pataje G S Prasanna; Helen B Stone; Rosemary S Wong; Jacek Capala; Eric J Bernhard; Bhadrasain Vikram; C N Coleman
Journal:  Transl Cancer Res       Date:  2012-06       Impact factor: 1.241

9.  The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion.

Authors:  Qiang Fu; Maaike Berbée; Marjan Boerma; Junru Wang; Herbert A Schmid; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2009-06       Impact factor: 2.841

Review 10.  Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy.

Authors:  Junru Wang; Marjan Boerma; Qiang Fu; Martin Hauer-Jensen
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.